Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 138

Similar articles for PubMed (Select 23148090)

1.

Long-term data on corticosteroids and mycophenolate mofetil treatment in lupus nephritis.

Yap DY, Ma MK, Mok MM, Tang CS, Chan TM.

Rheumatology (Oxford). 2013 Mar;52(3):480-6. doi: 10.1093/rheumatology/kes293. Epub 2012 Nov 12.

2.
3.

Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.

Chan TM, Tse KC, Tang CS, Mok MY, Li FK; Hong Kong Nephrology Study Group.

J Am Soc Nephrol. 2005 Apr;16(4):1076-84. Epub 2005 Feb 23.

4.

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.

Houssiau FA, D'Cruz D, Sangle S, Remy P, Vasconcelos C, Petrovic R, Fiehn C, de Ramon Garrido E, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern V, Depresseux G, Guillevin L, Cervera R; MAINTAIN Nephritis Trial Group.

Ann Rheum Dis. 2010 Dec;69(12):2083-9. doi: 10.1136/ard.2010.131995. Epub 2010 Sep 10.

5.

Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.

Sahin GM, Sahin S, Kiziltas S, Masatlioglu S, Oguz F, Ergin H.

Ren Fail. 2008;30(9):865-9. doi: 10.1080/08860220802353843.

PMID:
18925525
6.

A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.

F L, Y T, X P, L W, H W, Z S, H Z, Z H; MMF in Induction Therapy for Active Lupus Nephritis in Mainland China Study Group.

Lupus. 2008 Jul;17(7):622-9. doi: 10.1177/0961203308089428.

PMID:
18625634
7.

Maintenance immunosuppression with mycophenolate mofetil: long-term efficacy and safety after heart transplantation.

Dandel M, Jasaityte R, Lehmkuhl H, Knosalla C, Hetzer R.

Transplant Proc. 2009 Jul-Aug;41(6):2585-8. doi: 10.1016/j.transproceed.2009.06.031.

PMID:
19715979
8.

Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine.

Fischer-Betz R, Specker C, Brinks R, Aringer M, Schneider M.

Rheumatology (Oxford). 2013 Jun;52(6):1070-6. doi: 10.1093/rheumatology/kes425. Epub 2013 Feb 4.

9.

Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation.

Triemer HL, Pearson TC, Odom KL, Larsen CP.

Clin Transplant. 2000 Aug;14(4 Pt 2):413-20.

PMID:
10946781
10.

Mycophenolate mofetil versus azathioprine as maintenance therapy for lupus nephritis: a meta-analysis.

Feng L, Deng J, Huo DM, Wu QY, Liao YH.

Nephrology (Carlton). 2013 Feb;18(2):104-10. doi: 10.1111/nep.12006. Review.

PMID:
23113811
11.

Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study.

Laskari K, Mavragani CP, Tzioufas AG, Moutsopoulos HM.

Arthritis Res Ther. 2010;12(6):R208. doi: 10.1186/ar3184. Epub 2010 Nov 9.

12.

Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial.

Stoenoiu MS, Aydin S, Tektonidou M, Ravelingien I, le Guern V, Fiehn C, Remy P, Delahousse M, Petera P, Quémeneur T, Vasconcelos C, D'Cruz D, Gilboe IM, Jadoul M, Karras A, Depresseux G, Guillevin L, Cervera R, Cosyns JP, Houssiau FA; MAINTAIN Nephritis Trial Group.

Nephrol Dial Transplant. 2012 May;27(5):1924-30. doi: 10.1093/ndt/gfr553. Epub 2011 Nov 22.

13.

Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome.

Yap DY, Yu X, Chen XM, Lu F, Chen N, Li XW, Tang CS, Chan TM.

Nephrology (Carlton). 2012 May;17(4):352-7. doi: 10.1111/j.1440-1797.2012.01574.x.

PMID:
22295934
14.

Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.

Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.

Transpl Immunol. 2008 Nov;20(1-2):32-42. doi: 10.1016/j.trim.2008.08.005. Epub 2008 Sep 4.

PMID:
18773960
15.

The use of low-dose cyclophosphamide followed by AZA/MMF treatment in childhood lupus nephritis.

Baskin E, Ozen S, Cakar N, Bayrakci US, Demirkaya E, Bakkaloglu A.

Pediatr Nephrol. 2010 Jan;25(1):111-7. doi: 10.1007/s00467-009-1291-x. Epub 2009 Sep 1.

PMID:
19727839
16.

Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.

Li X, Ren H, Zhang Q, Zhang W, Wu X, Xu Y, Shen P, Chen N.

Nephrol Dial Transplant. 2012 Apr;27(4):1467-72. doi: 10.1093/ndt/gfr484. Epub 2011 Sep 13.

17.

Mycophenolate mofetil for remission induction in severe lupus nephritis.

Cross J, Dwomoa A, Andrews P, Burns A, Gordon C, Main J, Mathieson P, O'Donoghue D, Jayne D; Renal Association Clinical Trials Subcommittee.

Nephron Clin Pract. 2005;100(3):c92-100. Epub 2005 Apr 11.

PMID:
15824513
18.
19.

Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases.

Cortés-Hernández J, Torres-Salido MT, Medrano AS, Tarrés MV, Ordi-Ros J.

Nephrol Dial Transplant. 2010 Dec;25(12):3939-48. doi: 10.1093/ndt/gfq322. Epub 2010 Jun 10.

20.

Comparison between mycophenolate mofetil- and azathioprine-based immunosuppressions in clinical lung transplantation.

Zuckermann A, Klepetko W, Birsan T, Taghavi S, Artemiou O, Wisser W, Dekan G, Wolner E.

J Heart Lung Transplant. 1999 May;18(5):432-40.

PMID:
10363687
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk